Interestingly, these studies report an imbalance between proangiogenic and antiangiogenic placental factors in the serum of mothers carrying a fetus with CHD, characterized by elevated sFlt-1 and decreased PlGF levels.38 The gene discussed is PGF; the disease is coronary artery disorder.